The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

[1]  M. Davies,et al.  Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations , 2002, BMJ : British Medical Journal.

[2]  Simon Capewell,et al.  The current cost of heart failure to the National Health Service in the UK , 2002, European journal of heart failure.

[3]  J. Cleland,et al.  Diastolic heart failure: neglected or misdiagnosed? , 2002, Journal of the American College of Cardiology.

[4]  I. R. Manousos,et al.  Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH , 2002, European journal of heart failure.

[5]  J. Cohn,et al.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.

[6]  J. Senges,et al.  Clinical profile and management of heart failure: rural community hospital vs. metropolitan heart center , 2001, European journal of heart failure.

[7]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[8]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[9]  R. Lancashire,et al.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study , 2001, The Lancet.

[10]  E. Vicaut,et al.  Ambulatory heart failure management in private practice in France , 2001, European journal of heart failure.

[11]  N Freemantle,et al.  The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points , 2001, European journal of heart failure.

[12]  A Hofman,et al.  The prognosis of heart failure in the general population: The Rotterdam Study. , 2001, European heart journal.

[13]  S Capewell,et al.  More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure , 2001, European journal of heart failure.

[14]  A. Tonkin,et al.  Chronic heart failure in Australian general practice: The Cardiac Awareness Survey and Evaluation (CASE) Study , 2001, The Medical journal of Australia.

[15]  J. Cleland,et al.  The heart failure epidemic: exactly how big is it? , 2001, European heart journal.

[16]  J. Cleland,et al.  Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. , 2001, European heart journal.

[17]  R. Berger,et al.  Effect of β1 blockade with atenolol on progression of heart failure in patients pretreated with high‐dose enalapril , 2000, European journal of heart failure.

[18]  J. Cleland,et al.  Taking heart failure seriously , 2000, BMJ : British Medical Journal.

[19]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[20]  Joanne Eastaugh,et al.  The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.

[21]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[22]  A. Cohen-Solal,et al.  A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. , 2000, European heart journal.

[23]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[24]  J. Cleland,et al.  Systematic review of the management of atrial fibrillation in patients with heart failure. , 2000, European heart journal.

[25]  J. Cleland,et al.  Is the prognosis of heart failure improving? , 1999, Journal of the American College of Cardiology.

[26]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[27]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[28]  A. Cohen-Solal,et al.  Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative , 1999, European journal of heart failure.

[29]  J. Cleland,et al.  The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS) , 1999, European journal of heart failure.

[30]  F. Zannad,et al.  Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine. , 1999, Journal of the American College of Cardiology.

[31]  A Hofman,et al.  Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.

[32]  J. McMurray.  Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? , 1998, European heart journal.

[33]  J. Cleland,et al.  Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. , 1998, European heart journal.

[34]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[35]  Thierry C. Gillebert,et al.  How to diagnose diastolic heart failure , 1998 .

[36]  W. Paulus.  European Study Group on Diastolic Heart Failure , 1998 .

[37]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[38]  David M. Smith,et al.  The Sequelae of Hospitalization for Congestive Heart Failure Among Older Adults , 1997, Journal of the American Geriatrics Society.

[39]  A. Cowley,et al.  Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners? , 1997, International journal of cardiology.

[40]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[41]  D E Grobbee,et al.  The epidemiology of heart failure. , 1997, European heart journal.

[42]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[43]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[44]  D. Collett.  Modelling Binary Data , 1991 .

[45]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[46]  D. Seymour,et al.  A prospective study of elderly general surgical patients: I. Pre-operative medical problems. , 1989, Age and ageing.